The latest from MDFA
MDFA launches eye health video series
MDFA has released a new series of educational videos to help Aussies better understand macular disease.
Third anti-VEGF agent now reimbursed by PBS
On 1st October 2021, Beovu® became the third anti-VEGF drug to be subsidized by the Pharmaceutical Benefits Scheme for the treatment of wet age-related macular degeneration.
MDFA Annual General Meeting
Join MDFA on Thursday 9 December for our online Annual General Meeting (AGM) for 2021.
Age-related macular degeneration: webinar
Age-related macular degeneration (AMD) is Australia’s leading cause of legal blindness. Join MDFA’s webinar to learn more.
Potential new treatment for dry AMD
Apellis announces initial results from two phase III studies in geographic atrophy.
Vision Voice spring 2021 out now
The Spring 2021 Vision Voice leads with the Health Minister Greg Hunt, seeking to allay your concerns around Medicare rebate changes.
MBS eye injection: update
MDFA continues to advocate against a proposal to cut Medicare rebates for eye injections and met with the Health Minister in June 2021.
Don’t defer essential eye appointments during lockdown
Macular Disease Foundation Australia (MDFA) is seeking to clear up any confusion around deferring eye appointments during lockdown.
James Muecke MDFA ambassador
Macular Disease Foundation Australia is delighted to officially welcome Dr James Muecke AM on board as MDFA’s diabetic eye disease Ambassador.